Analysis of Latent Forms of Renin Using Antibodies Raised Against the Propart Segment of Human Prorenin: Validation with Representative Samples of Ovarian Cyst and Follicular Fluids

References

• Wang P. H., Do Y. S., Macaulay L., Shinagawa T., Anderson P. W., Baxter J. D. Identification of renal cathepsin B as human prorenin-processing enzyme. J. Biol. Chem. 1991; 266: 12633–12638
   PubMed Web of Science ®Google Scholar
• Heinrikson R. L., Hui J., Zurcher-Neely H., Poorman R. A. A structural model to explain the partial catalytic activity of human prorenin. Am. J. Hypertens. 1989; 2: 367–380
   PubMed Web of Science ®Google Scholar
• Nakayama K., Nagahama M., Kim W-S, Hatsuzawa K., Hashiba K., Murakami K. Prorenin is sorted into the regulatory secretory pathway independent of its processing to renin in mouse pituitary AtT-20 cells. FEBS Lett. 1989; 257: 89–92
   PubMed Web of Science ®Google Scholar
• Green D. W., Aykent S., Gierse J. K., Zupec M. E. Substrate specificity of recombinant human renal renin. Biochemistry 1990; 29: 3126–3123
   PubMed Web of Science ®Google Scholar
• Harrison T. M., Chidgey M. A.J., Brammar W. J., Adams G. J. The pro-peptide is not necessary for active renin secretion from transfected mammalian cells. Proteins 1989; 5: 259–265
   PubMed Web of Science ®Google Scholar
• Chidgey M. A.J., Harrison T. M. Renin is sorted to the regulated secretory pathway in transfected PC12 cells by a mechanism which does not require expression of the pro-peptide. Eur. J. Biochem. 1990; 190: 139–144
   PubMedGoogle Scholar
• Kim S-J, Hirose S., Miyazaki H., Ueno N., Higashimori K., Morinaga S., Kimura T., Sakakibara S., Murakami K. Identification of plasma inactive renin as prorenin with a site-directed antibody. Biochem. Biophys. Res. Commun. 1985; 126: 641–645
   PubMed Web of Science ®Google Scholar
• Hirose S., Kim S-J, Miyazaki H., Park Y-S, Murakami K. In vitro biosynthesis of human renin and identification of plasma inactive renin as an activation intermediate. J. Biol. Chem. 1985; 260: 16400–16405
   PubMedGoogle Scholar
• Gaillard I., Fehrentz J. A., Simon D., Badouaille G., Seyer R., Castro B., Pau B., Corvol P. Analysis of inactive renin by renin profragment monoclonal antibodies. FEBS Lett. 1986; 207: 100–104
   PubMed Web of Science ®Google Scholar
• Ishizuka Y., Iizumi S., Akiyama F., Hori H., Poorman R. A., Lobl T. J., Murakami K. Characterisation of monoclonal antibodies against human prorenin profragment and identification of active prorenins in plasma. J. Biochem. 1989; 106: 430–435
   PubMed Web of Science ®Google Scholar
• Sealey J. E., Glorioso N., Itskovitz J., Laragh J. H. Prorenin as a reproductive hormone. Am. J. Med. 1986; 81: 1041–1046
   PubMed Web of Science ®Google Scholar
• Glorioso N., Atlas S. A., Laragh J. H., Jewelewicz R, Sealey J. E. Prorenin in high concentrations in human ovarian follicular fluid. Science; 1986; 233: 1422–1425
   PubMed Web of Science ®Google Scholar
• Higashimori K., Mizuno K., Nakajo S., Boehm F. H., Marcott P. A., Egan D. A., Holleman W. H., Heusser C., Poisner A. M., Inagami T. Pure human inactive renin. J. Biol. Chem. 1989; 264: 14662–14667
   PubMed Web of Science ®Google Scholar
• Sealey J. E., Rubattu S. Prorenin and renin as separate mediators of tissue and circulating systems. Am. J. Hypertens. 1989; 2: 358–366
   PubMed Web of Science ®Google Scholar
• Sealey J. E., Lenz T. High levels of circulating prorenin in pregnancy. Am. J. Obs. Gynecol. 1988; 158: 681–682
   PubMed Web of Science ®Google Scholar
• Derkx F. H.M., Alberda A. T., De Jong F. H., Zeilmaker F. H., Makovitz J. W., Schalekamp M. A.D.H. Source of plasma prorenin in early and late pregnancy Observations in a patient with primary ovarian failure. J. Clin. Endocrinol. Metab. 1987; 65: 349–354
   PubMed Web of Science ®Google Scholar
• Do Y. S., Sherrod A., Lobo R. A., Paulson R. J., Shinagawa T., Chen S., Kjos S, Hsueh W. A. Human ovarian theca cells are a source of renin. Proc. Natl Acad. Sci. USA 1988; 85: 1957–1961
   PubMed Web of Science ®Google Scholar
• Richards A. D., Kay J., Dunn B. M., Bessant C. M., Charlton P. A. Inhibition of aspartic proteinases by synthetic peptides derived from the propart of human prorenin. Int. J. Biochem. 1992; 24: 297–301
   PubMedGoogle Scholar
• Kreisler J. M., Moller G. Effect of PPD on the specific immune response to heterologous red cells in vitro. J. Immunol. 1974; 112: 151–161
   PubMed Web of Science ®Google Scholar
• Lachmann P. J., Strangeways L., Vyakarnam A., Evan G. Raising antibodies by coupling peptides to PPD and immunizing BCG-sensitised animals. Synthetic Peptides as Antigens, R. Porter, J. Whelan. John Wiley, Chichester 1986; 25–27, CIBA Foundation Symposia 119
   Google Scholar
• Norey C. G., Lees W. E., Darke B. M., Stark J. M., Baker T. S., Cryer A., Kay J. Immunological distinction between piscine and mammalian metallothioneins. Comp. Biochem. Physiol. 1990; 95B: 597–601
   Google Scholar
• McIntyre G. D., Pau B., Hallett A., Leckie B. J., Szelke M. The purification of a high molecular weight, enzymatically inactive renin precursor from human kidney. J. Hypertens. 1984; 2: 205–310
   Google Scholar
• Campbell C. M., Charlton P. A., Grinham C. J., Mooney C. J., Pendlebury J. E. The rapid purification and partial characterisation of human serum angiotensinogen. Biochem. J. 1987; 243: 121–126
   PubMed Web of Science ®Google Scholar
• Heusser Ch. H., Bews J. P.A., Alkan S. S., Dietrich F. M., Wood J. M., de Gasparo M., Hofbauer K. G. Monoclonal antibodies to human renin; properties and applications. Clin. Exp. Hypertens. 1987; A9: 1259–1275
   Google Scholar
• Higaki I., Ogihara T., Imai N., Kumahara Y., Hontani S., Nishiura M., Ogawa H., Hirose S., Murakami K. A new sensitive direct radioimmunoassay for human plasma renin and its clinical application. J. Lab. Clin. Med. 1984; 104: 947–954
   PubMedGoogle Scholar
• Atlas S. A., Hesson T. E., Sealey J. E., Laragh J. H. Reversible acid-activation of inactive renin: evidence favouring a unimolecular reaction. Clin. Sci. 1982; 63: 167S–170S
   Web of Science ®Google Scholar
• Leckie B. J., McGhee N. K. Reversible activation-onactivation of renin in human plasma. Nature 1980; 288: 702–704
   PubMed Web of Science ®Google Scholar
• Hsueh W. A., Carlson E. J., Israel-Hagman M. Mechanism of acid-activation of renin-role of kallikrein in renin activation. Hypertension 1981; 3(Suppl I)I22–29
   PubMedGoogle Scholar
• Pitarresi T. M., Rubattu S., Heinrikson R., Sealey J. E. Reversible cryoactivation of recombinant human prorenin. J. Biol. Chem. 1992; 267: 11753–11759
   PubMed Web of Science ®Google Scholar
• Bessant C. M., Charlton P. A., Price-Jones M. J., Kay J., Reid W. A. Prorenin in ovarian cyst fluid. J. Clin. Pathol. 1990; 16: 784–785
   Google Scholar
• Pellicer A., Palumbo A., DeCherney A. H., Naftolin F. Blockage of ovulation by an angiotensin antagonist. Science 1988; 240: 1660–1661
   PubMed Web of Science ®Google Scholar
• Brar H. S., Kjos S. L., Dougherty W., Do Y-S., Tam H. B., Hsueh W. A. Increased fetoplacental active renin production in pregnancy-induced hypertension. Am. J. Obs. Gynecol. 1987; 157: 363–367
   PubMed Web of Science ®Google Scholar